Prospective, Multicenter Phase I–II Pilot Trial to Evaluate Efficacy and Safety of Lenalidomide Plus Rituximab-CHOP21 (LR-CHOP21) for Elderly Patients with Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Interim Analysis of the Intergruppo Italiano Linfomi (IIL) REAL07 Study
2010; Elsevier BV; Volume: 116; Issue: 21 Linguagem: Inglês
10.1182/blood.v116.21.2871.2871
ISSN1528-0020
AutoresUmberto Vitolo, Annalisa Chiappella, Angelo Michele Carella, Ileana Baldi, Giovannino Ciccone, Angela Giovanna Congiu, Gianluca Gaïdano, Pasqualina De Masi, Marco Ladetto, Alessandro Levis, Anna Marina Liberati, Lorella Orsucci, Vincenzo Pavone, Sonia Perticone, Alessandra Tucci, Manuela Zanni, Giuseppe Rossi,
Tópico(s)Acute Lymphoblastic Leukemia research
Referência(s)